Furukawa, Nozomi
Matsui, Hiroki
Sunaga, Hiroaki
Nagata, Kohzo
Hirayama, Masaaki
Obinata, Hideru
Yokoyama, Tomoyuki
Ohno, Kinji
Kurabayashi, Masahiko
Koitabashi, Norimichi
Article History
Received: 31 March 2024
Accepted: 8 October 2024
First Online: 23 October 2024
Declarations
:
: N.K. was supported by a joint research fund from Novartis Pharma, which provided the sacubitril/valsartan and valsartan used in the present study.
: The animal study was reviewed and approved by the Committee of Experimental Animal Research of Gunma University (14–063). All animal models and experimental procedures conformed to the NIH Guide for the Care and Use of Laboratory Animals and the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines (). Euthanasia techniques for experimental animals were performed in accordance with the American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals (2020).